Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Endocrinology · 01.12.2021 · 162 (12)
DOI: 10.1210/endocr/bqab134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 30.06.2021. Verfasst von Sharika Hanyroup und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuroendocrinology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Research Foundation South Africa, University of Pretoria.
Abstract (Originalsprache)
Mutations in G protein-coupled receptors (GPCRs) underlie numerous diseases. Many cause receptor misfolding and failure to reach the cell surface. Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the endoplasmic reticulum, stabilizing folding and “rescuing” cell surface expression. We previously demonstrated rescue of cell surface expression of luteinizing hormone receptor mutants by an allosteric agonist. Here we demonstrate that a similar approach can be employed to rescue mutant follicle-stimulating hormone receptors (FSHRs) with poor cell surface expression using a small-molecule FSHR agonist, CAN1404. Seventeen FSHR mutations described in patients with reproductive dysfunction were expressed in HEK 293T cells, and cell surface expression was determined by enzyme-linked immunosorbent assay of epitope-tagged FSHRs before/after treatment with CAN1404. Cell surface expression was severely reduced to ≤18% of wild-type (WT) for 11, modestly reduced to 66% to 84% of WT for 4, and not reduced for 2. Of the 11 with severely reduced cell surface expression, restoration to ≥57% of WT levels was achieved for 6 by treatment with 1 µM CAN1404 for 24 h, and a corresponding increase in FSH-induced signaling was observed for 4 of these, indicating restored functionality. Therefore, CAN1404 acts as a pharmacological chaperone and can rescue cell surface expression and function of certain mutant FSHRs with severely reduced cell surface expression. These findings aid in advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof of therapeutic principle for FSHR pharmacological chaperones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Neuroendocrinology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- Mitobridge Inc., Cambridge, MA, USA.
- CanWell Pharma Inc., Wellesley, MA, USA.
- Department of Integrative Biomedical Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
ORCID-Profile: Ross C Anderson, Robert P Millar, Claire L Newton
Förderung
- National Research Foundation South Africa
- University of Pretoria
Zitieren
APA
Hanyroup, S., Anderson, R. C., Nataraja, S., Yu, H. N., Millar, R. P., & Newton, C. L. (2021). Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors. Endocrinology, 162(12). https://doi.org/10.1210/endocr/bqab134
Vancouver
Hanyroup S, Anderson RC, Nataraja S, Yu HN, Millar RP, Newton CL. Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors. Endocrinology. 2021;162(12). doi:10.1210/endocr/bqab134
BibTeX
@article{Hanyroup2021,
author = {Hanyroup, Sharika and Anderson, Ross C and Nataraja, Selvaraj and Yu, Henry N and Millar, Robert P and Newton, Claire L},
title = {Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors},
journal = {Endocrinology},
year = {2021},
volume = {162},
number = {12},
doi = {10.1210/endocr/bqab134}
}
EUVIMED